Table IV.
Number of participants demonstrating conjunction and/or task‐specific activation
| Side | ROI | AM/ViVo | AVo/ViM | ||||
|---|---|---|---|---|---|---|---|
| Conjunction | AM | ViVo | Conjunction | AVo | ViM | ||
| Left | Thalamus | 6* | 4 | 2 | 10* | 1 | 1 |
| Brainstem | 2 | 0 | 1 | 5 | 1 | 0 | |
| pLPFC | 7* | 4 | 3 | 8* | 6* | 3 | |
| PM | 5 | 3 | 5 | 7* | 3 | 2 | |
| Pre‐SMA/SMA | 9* | 4 | 7* | 9* | 7* | 3 | |
| Anterior Cingulate | 8* | 5 | 3 | 11* | 3 | 5 | |
| Right | Brainstem | 3 | 0 | 1 | 3 | 2 | 0 |
| Anterior Insula | 6* | 4 | 3 | 7* | 2 | 2 | |
| pLPFC | 6* | 2 | 4 | 7* | 7* | 3 | |
| PM | 5 | 3 | 4 | 8* | 5 | 5 | |
| Pre‐SMA/SMA | 10* | 6* | 5 | 10* | 3 | 3 | |
| Anterior Cingulate | 7* | 5 | 5 | 9* | 0 | 3 | |
The total number of participants per cell is 12 (i.e., only subjects with sagittal prescriptions were analyzed in 2D). Cells with asterisks (*) have six or more participants, indicating that there is 99.72% confidence, using the Bonferroni corrected Clopper–Pearson test (see Methods section), that there is at least one participant with conjunction or task‐specific activation. SP, superior–posterior; pLPFC, posterior lateral prefrontal cortex; PM, premotor; SMA, supplementary motor area.